Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone acetonide is preferred for treating patchy alopecia areata due to fewer side effects.

Methylprednisolone pulse therapy works best for recent and specific types of severe alopecia areata.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Triamcinolone acetonide injections help hair regrow quickly in mild alopecia but not in severe cases.

Short-acting testosterone injections in a clinic are a preferred treatment for low testosterone because they work well, are convenient, and patients stick with the treatment.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Methylprednisolone treatment helps most alopecia areata patients, but young age, extensive hair loss, and low vitamin D can affect results.

Lower doses of dexamethasone can safely reduce high DHEAS levels in women with androgenic disorders.

Patients need better information about the risks of long-term steroid use.

Oral mini-pulse methylprednisolone is an effective and safe treatment for alopecia areata.

Use lower concentrations of triamcinolone acetonide to reduce steroid-induced scalp atrophy.

Intralesional steroid therapy is useful for treating various skin conditions.

Intralesional Triamcinolone acetonide injections are safe and effective for treating alopecia areata.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

Injecting triamcinolone into the eyebrow area may help eyelash regrowth in alopecia areata patients.

Oral methylprednisolone pulse therapy helped an 11-year-old regrow 80% of his hair in six months.

Mini pulse corticosteroid therapy with oral dexamethasone is effective and has fewer side effects for treating extensive alopecia areata.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Triamcinolone can regrow hair in alopecia areata, but the effect is temporary.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

Higher doses of prednisone and triamcinolone acetonide successfully treated 8 out of 10 alopecia totalis patients.

The article concludes that proper injection techniques and patient education can prevent serious skin reactions from multiple sclerosis medications.

Intralesional triamcinolone effectively reduces pain and inflammation in hidradenitis suppurativa flares.

Medroxyprogesterone acetate injections are more effective than topical ointment in treating excessive hair growth in women.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

A 300 mg monthly pulse of prednisolone effectively and safely treats widespread alopecia areata.

Large doses of glucocorticoids are not suitable for general use in treating severe alopecia areata due to inconsistent results and risks.

Injecting steroids like Triamcinolone Acetonide for skin treatments can cause Cushing's Syndrome.